Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injuryâ©.

Ersan, Sibel; Celik, Asli; Tanrisev, Mehmet; Kose, Isil; Cavdar, Zahide; Unlu, Mehtat; Kocak, Ayse; Ural, Cemre; Yilmaz, Banu; Kose, Timur

Pretreatment with paricalcitol attenuates level and expression of matrix metalloproteinases in a rat model of renal ischemia-reperfusion injuryâ©.

Ersan, Sibel; Celik, Asli; Tanrisev, Mehmet; Kose, Isil; Cavdar, Zahide; Unlu, Mehtat; Kocak, Ayse; Ural, Cemre; Yilmaz, Banu; Kose, Timur.

Clin Nephrol ; 88(11): 231-238, 2017 Nov.

Article in En | MEDLINE | ID: mdl-28737133

Subject(s)

Acute Kidney Injury/drug therapy; Ergocalciferols/therapeutic use; Kidney/blood supply; Matrix Metalloproteinase 2/analysis; Matrix Metalloproteinase 9/analysis; Reperfusion Injury/drug therapy; Acute Kidney Injury/enzymology; Animals; Disease Models, Animal; Male; Rats; Rats, Wistar; Reperfusion Injury/enzymology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reperfusion Injury / Ergocalciferols / Matrix Metalloproteinase 2 / Matrix Metalloproteinase 9 / Acute Kidney Injury / Kidney Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Nephrol Year: 2017 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google